(Total Views: 533)
Posted On: 04/25/2021 1:52:07 PM
Post# of 145248
![Avatar](https://investorshangout.com/images/ProfileImages/573000060_60093_FD245EF6-37BD-4C88-9356-29519D0376AD.jpeg)
Given the recent talk about leronlimab’s cancer results, more specifically CTCs, I figured I’d share a recent article from Dr. BP on CTCs. CTC is a valuable measurement for CYDY and the path forward. Incelldx has a new patent for detecting PD-L1 on CTCs, so the science is improving. Let’s get a PR/8K with the CTC/CAML data so the trial enrollment can speed up rand results can be announced.
https://lsc-pagepro.mydigitalpublication.com/...8&pp=1
https://lsc-pagepro.mydigitalpublication.com/...8&pp=1
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)